ACS:180 AND ADVIA CENTAUR IPTH IMMUNOASSAY— 510(k) K020217

Substantially Equivalent

Bayer Diagnostics Corp.

FDA 510(k) clearance K020217 for ACS:180 AND ADVIA CENTAUR IPTH IMMUNOASSAY, Substantially Equivalent on 2002-03-15. Applicant: Bayer Diagnostics Corp.. Device class: 1.

Clearance details

Applicant
Bayer Diagnostics Corp.
Product code
Code JJX
Device class
Class 1
Regulation
21 CFR 862.1660
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Tarrytown, NY, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code JJX

view all

More clearances from Bayer Diagnostics Corp.

view all

Adverse events under product code JJX

product code JJX
Other
2
Total
2

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recalls naming K020217

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K020217.

Data sourced from openFDA. This site is unofficial and independent of the FDA.